To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
New to F1000? See this week’s top article below for a free preview of a Recommendation.
In current practice, potent bisphosphonates are administered to patients with some cancers at doses which are at least 10-fold higher than those used for reduction of osteoporotic fracture risk. Treatment modestly reduces the...
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
17 Recommendations, most recent by
Past 7 Days
New Articles Recommended
Past 30 Days
31Articles Classified As Changes Clinical Practice3,989 total
457Articles Classified As Confirmation27,480 total
179Articles Classified As Controversial8,182 total
537Articles Classified As Clinical Trial27,971 total
239Articles Classified As Interesting Hypothesis14,656 total
70Articles Classified As Review / Commentary5,681 total
345Articles Classified As Good for Teaching3,749 total
135Articles Classified As Technical Advance7,156 total
26Articles Classified As Refutation1,634 total
66Articles Classified As Novel Drug Target1,735 total
1,080Articles Classified As New Finding51,406 total
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.